A hepatobiliary iminodiacetic acid (HIDA) scan is a nuclear imaging test that uses a radioactive tracer to track the movement of bile from the liver to the gallbladder and small intestine. Bile is a digestive fluid produced by the liver that helps to break down fats. HIDA scans are used to diagnose a variety of conditions, including gallbladder inflammation (cholecystitis), gallstones, and bile duct obstruction.
The HIDA scan market is experiencing steady growth due to factors such as increased disease prevalence, technological advancements, and a focus on non-invasive diagnostic procedures. Key trends, including the integration of hybrid imaging and the use of AI, are shaping the market's future. As the healthcare industry continues to evolve, the HIDA scan market is expected to play a pivotal role in the diagnosis and management of hepatobiliary disorders.
The HIDA Scan Market demand is expected to grow USD 220 Million at a CAGR of 5.30% during the forecast period 2023 to 2030. This growth is attributed to a number of factors, including:
- Increasing prevalence of gallbladder diseases: Gallbladder disease is a common condition, affecting millions of people worldwide. The prevalence of gallbladder disease is expected to increase in the coming years due to factors such as obesity, aging, and unhealthy diets.
- Technological advancements: Technological advancements in nuclear imaging devices have led to the development of more accurate and efficient HIDA scans. This has made HIDA scans a more attractive option for physicians and patients alike.
- Rising awareness of HIDA scans: Rising awareness of HIDA scans among physicians and patients is another factor driving the growth of the HIDA scan market.
HIDA Scan Market Segmentation
The HIDA scan market segment can be segmented on the basis of product, indication, and end user.
Product segmentation:
- Radiopharmaceuticals
- Imaging devices
Indication segmentation:
- Cholecystitis
- Gallstones
- Bile duct obstruction
- Liver disease
- Other
End user segmentation:
- Hospitals
- Diagnostic imaging centers
- Ambulatory surgical centers
HIDA Scan Market Regional Analysis
The global HIDA scan market is dominated by North America, followed by Europe and Asia Pacific. North America accounts for the largest share of the market due to the high prevalence of gallbladder diseases in the region, the widespread adoption of advanced nuclear imaging technologies, and the high awareness of HIDA scans among physicians and patients. Europe is the second-largest market for HIDA scans, followed by Asia Pacific. The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period due to factors such as the increasing prevalence of gallbladder diseases, the growing demand for advanced diagnostic imaging technologies, and the rising awareness of HIDA scans.
HIDA Scan Market Key Players
Some of the key players in the global HIDA scan market include:
- GE Healthcare
- Philips Healthcare
- Siemens Healthineers
- Fujifilm
- Hitachi Medical Systems
- Bracco Imaging
- IBA Molecular Imaging
- Cardinal Health
- McKesson
- Amersham Health
- Curium
HIDA Scan Market Trends
Some of the key trends in the global HIDA scan market include:
- Increasing demand for hybrid imaging devices: Hybrid imaging devices, such as PET/CT scanners, combine the capabilities of two or more imaging modalities to provide more comprehensive and accurate images. Hybrid imaging devices are being increasingly used for HIDA scans, as they can provide more information about the structure and function of the biliary system.
- Growing popularity of point-of-care HIDA scans: Point-of-care HIDA scans are becoming increasingly popular, as they can provide results quickly and conveniently. Point-of-care HIDA scans are typically performed in hospital emergency departments and outpatient clinics.
- Rising use of HIDA scans for pediatric patients: HIDA scans are becoming increasingly used for pediatric patients, as they are a safe and effective way to diagnose gallbladder diseases in children.
HIDA Scan Market Conclusion
The global HIDA scan market is expected to grow steadily in the coming years due to a number of factors, including the increasing prevalence of gallbladder diseases, technological advancements, and rising awareness of HIDA scans. The market is dominated by North America, followed by Europe and Asia Pacific. Asia Pacific is expected to be the fastest-growing market during the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
